1. Submitted To- Dr. Rameshwar Das
Associate Professor
Submitted By- Muskan
M-506
M.Pharm.
1st Semester
2. Introduction
Advantages and Limitations
Structure of Skin
Components of Transdermal Patch
Penetration Enhancers
Classification of TDDS
3. Transdermal drug delivery is defined as a self contained
discrete dosage form, which when applied to the intact skin,
will deliver the drug at a controlled rate to the systemic
circulation
4. Avoidance of first-pass metabolism
Long duration of action
Ease of termination of drug action
Reduces frequency of dosing
No interference with gastric and intestinal fluids
Suitable for administered of drug having-
a. Very short half-life, e.g. nitroglycerine.
b. Narrow therapeutic window.
c. Poor oral availability
5. Heat, cold, sweating and showering prevent the patch from
sticking to the surface of the skin for more than one day. A
new patch has to be applied daily.
Skin irritation and allergic response
Restricted to Potent drugs.
Cannot be used for Large molecules(>500 D)
Limited Skin Permeability
6.
7. Epidermis It consists of 5 layers-Stratum
corneum
Stratum lucidum
Stratum granulosum
Stratum spinosum
Stratum germinativum
Dermis Drug is absorbed in this layer
It consists of-
Sweat duct
Hair follicle
Sebaceous gland
Subcutaneous It consists of fat containing areolar
tissue
10. Backing MEmbrane It act as a protivar layer and avoids back
diffusion of drug . It is made up of either
of these-
Polypropylene
Polyethylene
Polyester
Drug Permeable Membrane It act as a rate controlling membrane
It is made up of either of these-
Ethylene vinyl acetate
Microporous polyethylene
Adhesives It enables the patch to adhere to the surface
of skin (stick). It is classified as follows –
Rubber based pressure sensitive adhesives
Acrylic based pressure sensitive adhesive
Release liners It consists of anti-adherent coating
Silicones
Fluoro polymers
11. Suitable Drug Candidate
Physico chemical properties of
drug-
Should have MW less than 1000
daltons(800-1000)
Should have affinity for both
lipophilic and hydrophilic phases
Should have low melting pont
Biological properties of drug-
Should be potent(less than 20mg)
Half life should be short
Must not induce a cutaneous irritant or
allergic response
Drugs which degrade in the GI tract or
inactivated by hepatic first pass effect
are suitable candidate
Tolerance to the drug must not
develop
Drugs which has to be administered
for a longer period of time can be
formulated
Drugs which cause adverse effects to
non target tissues can also be
formulated
12. To enhance stratum corneum permeability
Solvents water,ethanol, methanol,DMS, homologs
of methyl sulphoxide, dimethyl
acetamide
Surfactants Anionic surfactants-
Dioctyl sulpho succinate, SLS
Non ionic surfactants-
Pluronic F127, Pluronic F68,etc.
Bile salts-
Sodium taurocholate, sodium deoxy
cholate, sodium tauroglycocholate.
Miscellaneous Urea-hydrating and keratolytic agent,N,N-
dimethyl-m-toluamide, calcium
thioglycolate
Potential Permeation Enhancers Euclyptol,di-o-methyl-B-cyclodextrin and
soyabean casein